1. Market Research
  2. > Pharmaceutical
  3. > Therapy
  4. > Oncology Market Trends
  5. > Oncology Industry in Japan Market Research & Statistics

Oncology Industry in Japan Market Research & Statistics

About 100 reports

Download Unlimited Documents from Trusted Public Sources

Global Therapy Market and Oncology Market

  • March 2016
    26 pages
  • Therapy  

    Oncology  

    Monoclonal Anti...  

  • United States  

    Japan  

    World  

View report >

Global Therapy Market

  • June 2018
    5 pages
  • Cancer  

    Gastric Cancer  

    Colorectal Canc...  

  • World  

    Japan  

    Australia  

View report >

Chemotherapy Market in Japan

  • April 2018
    13 pages
  • Chemotherapy  

  • Japan  

View report >

Cancer Statistics and Monoclonal Antibody Market in Japan

  • April 2018
    2 pages
  • Cancer  

    Lung Cancer  

    Monoclonal Anti...  

  • Japan  

View report >

Lung Cancer Statistics in Japan - Forecast

  • March 2018
    4 pages
  • Lung Cancer  

    Oncology  

    Chemotherapy  

  • Japan  

    United States  

    World  

View report >

Lung Cancer Statistics in Japan - Forecast

  • March 2018
    4 pages
  • Lung Cancer  

    Therapy  

    HIV Antiviral  

  • Japan  

    United States  

    World  

View report >

Global Cancer Statistics

  • January 2018
    7 pages
  • Cancer  

    Oncology  

  • United States  

    Japan  

    World  

View report >

Therapy Market and Chemotherapy Market in Japan

  • January 2018
    8 pages
  • Therapy  

    Chemotherapy  

    Hospital  

  • Japan  

    Asia  

View report >

Hepatitis Statistics and Therapy Market

  • October 2017
    2 pages
  • Hepatitis  

    Therapy  

    Cancer  

  • Europe  

    United States  

    China  

View report >

Therapy Market in Asia and Japan

  • October 2017
    77 pages
  • Therapy  

    Targeted Therap...  

    Lung Cancer  

  • Asia  

View report >

Search in Oncology Industry (54 reports)
Parent industry: Therapy

88 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 750 - $ 10995)

Pancreatic Cancer: Opportunity Analysis and Forecast to 2026

Pancreatic Cancer: Opportunity Analysis and Forecast to 2026

  • $ 10995
  • Industry report
  • April 2018
  • by GlobalData

Pancreatic Cancer: Opportunity Analysis and Forecast to 2026SummaryPancreatic cancer is set to become the second leading cause of cancer-related deaths in the US in 2020 after lung cancer, despite accounting ...

Head and Neck Squamous Cell Carcinoma - Opportunity Ana ... $ 10995 March 2018

PharmaPoint: Prostate Cancer - Global Drug Forecast and ... $ 10995 November 2017

OpportunityAnalyzer: Acute Myeloid Leukemia - Opportuni ... $ 10995 July 2017

PharmaPoint: HER2-Positive Breast Cancer - Global Drug ... $ 10995 June 2017

OpportunityAnalyzer: Bladder Cancer - Opportunity Analy ... $ 10995 April 2017

Drug Analysis: Fasenra $ 10000 February 2018

Drug Overview: Fasenra $ 10000 February 2018

Drug Analysis: Eligard $ 10000 January 2018

Drug Analysis: Zoladex $ 10000 January 2018


ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on